Related Experiment Video
Updated: Feb 10, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Molecularly-targeted therapy for the oral cancer stem cells
Yuichi Ohnishi1,2, Hiroki Yasui1, Masami Nozaki2
1Second Department of Oral and Maxillofacial Surgery, Osaka Dental University, Hirakata, Osaka 573-1121, Japan.
Abstract:
Human cancer tissues are heterogeneous in nature and become differentiated during expansion of cancer stem cells (CSCs). CSCs initiate tumorigenesis, and are involved in tumor recurrence and metastasis. Furthermore, data show that CSCs are highly resistant to anticancer drugs. Cetuximab, a specific anti-epidermal growth factor receptor (EGFR) monoclonal antibody, is used in cancer treatment. Although development of resistance to cetuximab is well recognized, the underlying mechanisms remain unclear. Lapatinib, a dual inhibitor of epidermal growth factor receptor (EGFR)/ErbB2, has antiproliferative effects and is used to treat patients with ErbB2-positive metastatic breast cancer. In this review, cetuximab and lapatinib-resistant oral squamous cell carcinoma (OSCC) cells proliferation and migration signal transduction passway is discussed by introducing our research.
Insights
Cancer stem cells (CSCs) drive tumor growth and drug resistance. This review explores resistance mechanisms to cetuximab and lapatinib in oral squamous cell carcinoma (OSCC) by examining signaling pathways.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Human cancers exhibit heterogeneity, with cancer stem cells (CSCs) driving tumorigenesis, recurrence, and metastasis.
- CSCs are recognized for their inherent resistance to conventional anticancer therapies.
- Resistance to targeted therapies like cetuximab and lapatinib is a significant clinical challenge.
Purpose of the Study:
- To review and discuss the signaling pathways involved in cetuximab and lapatinib resistance in oral squamous cell carcinoma (OSCC) cells.
- To elucidate the mechanisms underlying CSC-mediated resistance to EGFR-targeted therapies.
- To present novel research findings on the signal transduction pathways in resistant OSCC cells.
Main Methods:
- Review of existing literature on CSCs, targeted therapy resistance, and OSCC.
- Analysis of signal transduction pathways implicated in cetuximab and lapatinib resistance.
- Introduction of specific research data on OSCC cell proliferation and migration.
Main Results:
- CSCs play a critical role in the development of resistance to EGFR inhibitors.
- Specific signaling pathways are identified as key mediators of resistance in OSCC.
- Understanding these pathways offers potential targets for overcoming therapeutic resistance.
Conclusions:
- Targeting CSCs and their associated signaling pathways is crucial for overcoming resistance to cetuximab and lapatinib in OSCC.
- Further research into these pathways may lead to novel therapeutic strategies for managing resistant cancers.
- This review highlights the importance of investigating CSC biology in the context of targeted therapy resistance.
More Related Videos
09:34A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
Published on: October 25, 2018
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adult Stem Cells